Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation

By Forns X.   Garcia-Retortillo M.   Serrano T.   Feliu A.   Suarez F.   de la Mata M.   Garcia-Valdecasas J.C.   Navasa M.   Rimola A.   Rodes J.  

Journal of Hepatology, Vol. 39, Iss. 3, 2003-09 ,pp. : 389-396

Elsevier

Access to resources Recommend Favorite

High Ascitic Fluid Leptin Levels in Patients with Decompensated Liver Cirrhosis and Sterile Ascites: Relationship with TNF-α Levels

By Giannini Edoardo   Romagnoli Paola   Tenconi Gian Luca   Botta Federica   Malfatti Federica   Chiarbonello Bruno   Mamone Mario   Barreca Tommaso   Testa Roberto  

Digestive Diseases and Sciences, Vol. 49, Iss. 2, 2004-02 ,pp. : 275-280

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Factors Predicting the Effect of Tolvaptan for Refractory Ascites in Patients with Decompensated Liver Cirrhosis

By  

Digestive Diseases, Vol. 34, Iss. 6, 2016-10 ,pp. : 659-664

Karger

Access to resources Recommend Favorite

Treatment of patients with decompensated post-hepatitis C cirrhosis before liver transplantation: strategy to prevent hepatitis C virus (HCV) recurrence?

By Zarski J.-P.   Hilleret M.-N.  

Journal of Hepatology, Vol. 39, Iss. 3, 2003-09 ,pp. : 435-436

Elsevier

Access to resources Recommend Favorite

A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose–response of tolvaptan in patients with decompensated liver cirrhosis

By Okita Kiwamu   Sakaida Isao   Okada Mitsuru   Kaneko Akira   Chayama Kazuaki   Kato Michio   Sata Michio   Yoshihara Naomasa   Ono Noriyuki   Murawaki Yoshikazu  

Journal of Gastroenterology, Vol. 45, Iss. 9, 2010-09 ,pp. : 979-987

Springer Publishing Company

Access to resources Recommend Favorite